Sign In
Buy BNGO
$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway
08:00am, Wednesday, 28'th Feb 2024
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (“Bionano”) (Nasdaq: BNGO) today announced that is has amended the convertible debt financing the company entered into in Octobe
7 Penny Stocks to Buy on the Dip: February 2024
01:10pm, Wednesday, 07'th Feb 2024
Now might be a good time to consider scooping up shares of penny stocks to buy on the dip. However, caution is essential, as penny stocks can be volatile and speculative.
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
08:00am, Wednesday, 31'st Jan 2024
SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will participate in the BTIG
SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the second interim report from an ongoing clinical trial designed to support esta
Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping
08:00am, Tuesday, 23'rd Jan 2024
SAN DIEGO, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the full commercial release of the Stratys™ system, the Company's system for high throughput optic
SAN DIEGO, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc (Nasdaq: BNGO) today announced its 2024 Symposium lineup of 33 oral presentations delivered by 26 different customers worldwide featu
Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings
05:53am, Wednesday, 17'th Jan 2024
On Wall Street zeroes can become heroes relatively quickly. For example, in the past the Street hated Roku (NASDAQ: ROKU ), Intel (NASDAQ: INTC ), Shopify (NYSE: SHOP ) and Pinterest (NYSE: PINS ) and
Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing
After Plunging -23.84% in 4 Weeks, Here's Why the Trend Might Reverse for Bionano Genomics, Inc. (BNGO)
11:17am, Friday, 17'th Nov 2023
Bionano Genomics, Inc. (BNGO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analyst
Bionano Genomics, Inc. (BNGO) Presents at Stifel Healthcare Conference (Transcript)
03:23pm, Wednesday, 15'th Nov 2023
Bionano Genomics, Inc. (NASDAQ:BNGO ) Stifel Healthcare Conference Call November 15, 2023 1:50 PM ET Company Participants Erik Holmlin - CEO Conference Call Participants Dan Arias - Stifel Dan Arias O
3 Stocks That Are Poised to Generate Outsized Returns
05:00am, Friday, 10'th Nov 2023
In general, stocks generate outsized returns because the Street has been overly bearish on their outlook. Due to the Street's overdone high interest rate concerns, it's now unduly pessimistic about ma
Bionano Genomics, Inc. (BNGO) Q3 2023 Earnings Call Transcript
06:58pm, Wednesday, 08'th Nov 2023
Bionano Genomics, Inc. (NASDAQ:BNGO ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants David Holmes - Investor Relations Erik Holmlin - Chief Executive Officer Gülsen
Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023
08:00am, Wednesday, 01'st Nov 2023
SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, November 8, 2023, at 4:30 p.m. E
3 Deeply Undervalued Growth Stocks
12:28pm, Friday, 27'th Oct 2023
One of the New York Yankees' most well-known players', Yogi Berra, famous for his strange, yet funny statements, used to say, “This is deja vu all over again.” That's how I feel about U.S. stocks
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's What You Should Know
01:32pm, Thursday, 21'st Sep 2023
Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
